Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
The Next Paradigm Shift in the Management of Clear Cell Renal Cancer: Radiogenomics-Definition, Current Advances, and Future Directions
Nikhil Gopal et al.
CANCERS (2022)
Predictive Value of CT-Based Radiomics in Distinguishing Renal Angiomyolipomas with Minimal Fat from Other Renal Tumors
Zhiwei Han et al.
DISEASE MARKERS (2022)
Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis
Sohyun Park et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)
Differentiating Benign from Malignant Renal Tumors Using T2-and Diffusion-Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists
Qing Xu et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2022)
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer
Nicola Antonio di Meo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Radiogenomics in Clear Cell Renal Cell Carcinoma: A Review of the Current Status and Future Directions
Sari Khaleel et al.
CANCERS (2022)
MRI-Based Radiomics and Urine Creatinine for the Differentiation of Renal Angiomyolipoma With Minimal Fat From Renal Cell Carcinoma: A Preliminary Study
Lian Jian et al.
FRONTIERS IN ONCOLOGY (2022)
A Radiomic-based Machine Learning Algorithm to Reliably Differentiate Benign Renal Masses from Renal Cell Carcinoma
Nima Nassiri et al.
EUROPEAN UROLOGY FOCUS (2022)
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study
Francesco Cianflone et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2022)
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
Nicola Antonio di Meo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome
Giuseppe Lucarelli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Intratumoral Resolution of Driver Gene Mutation Heterogeneity in Renal Cancer Using Deep Learning
Paul H. Acosta et al.
CANCER RESEARCH (2022)
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2022)
A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma
Jiahao Gao et al.
FRONTIERS IN IMMUNOLOGY (2022)
Radiomics in prostate cancer: an up-to-date review
Matteo Ferro et al.
THERAPEUTIC ADVANCES IN UROLOGY (2022)
Differentiation of benign from malignant solid renal lesions with MRI-based radiomics and machine learning
Ruben Ngnitewe Massa'a et al.
ABDOMINAL RADIOLOGY (2022)
Differentiating renal epithelioid angiomyolipoma from clear cell carcinoma: using a radiomics model combined with CT imaging characteristics
Taek Min Kim et al.
ABDOMINAL RADIOLOGY (2022)
Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation
Shunya Matsumoto et al.
ABDOMINAL RADIOLOGY (2022)
Comprehensive evaluation of68Ga-PSMA-11 PET/CT parameters for discriminating pathological characteristics in primary clear-cell renal cell carcinoma
Jie Gao et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
2-[18F]FDG PET/CT parameters associated with WHO/ISUP grade in clear cell renal cell carcinoma
Yanyan Zhao et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Shape and texture-based radiomics signature on CT effectively discriminates benign from malignant renal masses
Felix Y. Yap et al.
EUROPEAN RADIOLOGY (2021)
Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept
Zine-Eddine Khene et al.
WORLD JOURNAL OF UROLOGY (2021)
Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy
Gian Maria Busetto et al.
WORLD JOURNAL OF UROLOGY (2021)
Validation of CT radiomics for prediction of distant metastasis after surgical resection in patients with clear cell renal cell carcinoma: exploring the underlying signaling pathways
Yuanshen Zhao et al.
EUROPEAN RADIOLOGY (2021)
The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology
Lin Shui et al.
FRONTIERS IN ONCOLOGY (2021)
A convention-radiomics CT nomogram for differentiating fat-poor angiomyolipoma from clear cell renal cell carcinoma
Yanqing Ma et al.
SCIENTIFIC REPORTS (2021)
A CT-Based Tumoral and Mini-Peritumoral Radiomics Approach: Differentiate Fat-Poor Angiomyolipoma from Clear Cell Renal Cell Carcinoma
Yanqing Ma et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Exploration of an Integrative Prognostic Model of Radiogenomics Features With Underlying Gene Expression Patterns in Clear Cell Renal Cell Carcinoma
Yeqian Huang et al.
FRONTIERS IN ONCOLOGY (2021)
Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma
Hao Zeng et al.
Aging-US (2021)
Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes
Stefano Salciccia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
PET Molecular Imaging: A Holistic Review of Current Practice and Emerging Perspectives for Diagnosis, Therapeutic Evaluation and Prognosis in Clinical Oncology
Valentin Duclos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A Novel Radiogenomics Biomarker Based on Hypoxic-Gene Subset: Accurate Survival and Prognostic Prediction of Renal Clear Cell Carcinoma
Jiahao Gao et al.
FRONTIERS IN ONCOLOGY (2021)
Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art
Michele Marchioni et al.
CURRENT UROLOGY REPORTS (2021)
Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform
Durga Udayakumar et al.
CLINICAL CANCER RESEARCH (2021)
Radiomic profiling of clear cell renal cell carcinoma reveals subtypes with distinct prognoses and molecular pathways
Peng Lin et al.
TRANSLATIONAL ONCOLOGY (2021)
Radiomics models based on enhanced computed tomography to distinguish clear cell from non-clear cell renal cell carcinomas
Ping Wang et al.
SCIENTIFIC REPORTS (2021)
Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy
Weimin Zhong et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Cost-effectiveness Analysis of 99mTc-sestamibi SPECT/CT to Guide Management of Small Renal Masses
Zhuo T. Su et al.
EUROPEAN UROLOGY FOCUS (2021)
Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization
Matteo Ferro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium
Yasmin Abu-Ghanem et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)
Michele Marchioni et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Grading of Clear Cell Renal Cell Carcinomas by Using Machine Learning Based on Artificial Neural Networks and Radiomic Signatures Extracted From Multidetector Computed Tomography Images
Xiaopeng He et al.
ACADEMIC RADIOLOGY (2020)
Radiologic-Radiomic Machine Learning Models for Differentiation of Benign and Malignant Solid Rena Masses: Comparison With Expert-Level Radiologists
Xue-Ying Sun et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2020)
Radiomics of small renal masses on multiphasic CT: accuracy of machine learning-based classification models for the differentiation of renal cell carcinoma and angiomyolipoma without visible fat
Ruimeng Yang et al.
EUROPEAN RADIOLOGY (2020)
A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma
Pei Nie et al.
EUROPEAN RADIOLOGY (2020)
Usefulness of CT texture analysis in differentiating benign and malignant renal tumours
Y. Deng et al.
CLINICAL RADIOLOGY (2020)
Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research
Aikseng Ooi
SEMINARS IN CANCER BIOLOGY (2020)
Value of radiomics in differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma
Yajuan Li et al.
ABDOMINAL RADIOLOGY (2020)
Prediction of Benign and Malignant Solid Renal Masses: Machine Learning-Based CT Texture Analysis
Cagri Erdim et al.
ACADEMIC RADIOLOGY (2020)
Automated differentiation of benign renal oncocytoma and chromophobe renal cell carcinoma on computed tomography using deep learning
Amir Baghdadi et al.
BJU INTERNATIONAL (2020)
Deep Learning to Distinguish Benign from Malignant Renal Lesions Based on Routine MR Imaging
Ianto Lin Xi et al.
CLINICAL CANCER RESEARCH (2020)
Predicting the ISUP grade of clear cell renal cell carcinoma with multiparametric MR and multiphase CT radiomics
Enming Cui et al.
EUROPEAN RADIOLOGY (2020)
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
Peter Strom et al.
LANCET ONCOLOGY (2020)
Mutations in renal cell carcinoma
Christopher D'Avella et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Can whole-tumor radiomics-based CT analysis better differentiate fat-poor angiomyolipoma from clear cell renal cell caricinoma: compared with conventional CT analysis?
Yanqing Ma et al.
ABDOMINAL RADIOLOGY (2020)
Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings
Zhan Feng et al.
FRONTIERS IN ONCOLOGY (2020)
Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma (BHP RCC)
Pedram Argani et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma
Pavlos Msaouel et al.
CANCER CELL (2020)
Discriminating malignant and benign clinical T1 renal masses on computed tomography A pragmatic radiomics and machine learning approach
Johannes Uhlig et al.
MEDICINE (2020)
Characterization of solid renal neoplasms using MRI-based quantitative radiomics features
Daniela Said et al.
ABDOMINAL RADIOLOGY (2020)
Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study
Hye Won Lee et al.
CANCERS (2020)
Applications of Artificial Intelligence to Prostate Multiparametric MRI (mpMRI): Current and Emerging Trends
Michelle D. Bardis et al.
CANCERS (2020)
Semi-quantitative F-18-FDG PET/computed tomography parameters for prediction of grade in patients with renal cell carcinoma and the incremental value of diuretics
Harpreet Singh et al.
NUCLEAR MEDICINE COMMUNICATIONS (2020)
FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation
Hongjing Zhu et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2020)
MR texture analysis in differentiating renal cell carcinoma from lipid-poor angiomyolipoma and oncocytoma
Abdul Razik et al.
BRITISH JOURNAL OF RADIOLOGY (2020)
Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes
Nicholas Baniak et al.
HISTOPATHOLOGY (2020)
Renal Cell Carcinoma: Predicting DNA Methylation Subtyping and Its Consequences on Overall Survival With Computed Tomography Imaging Characteristics
Taihen Yu et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2020)
The role of Tc-99m MIBI scintigraphy in clinical T1 renal mass assessment: Does it have a real benefit?
Tariq Asi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma
Giuseppe Lucarelli et al.
METABOLITES (2020)
Diagnostic utility of genetic testing in patients undergoing renal biopsy
Katherine A. Benson et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2020)
Interplay between male testosterone levels and the risk for subsequent invasive respiratory assistance among COVID-19 patients at hospital admission
Stefano Salciccia et al.
ENDOCRINE (2020)
Combining molecular and imaging metrics in cancer: radiogenomics
Roberto Lo Gullo et al.
INSIGHTS INTO IMAGING (2020)
Radiogenomics in renal cell carcinoma
Francesco Alessandrino et al.
ABDOMINAL RADIOLOGY (2019)
Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations Between mRNA-Based Subtyping and CT Imaging Features
Lan Bowen et al.
ACADEMIC RADIOLOGY (2019)
Clear Cell Renal Cell Carcinoma: Machine Learning-Based Quantitative Computed Tomography Texture Analysis for Prediction of Fuhrman Nuclear Grade
Ceyda Turan Bektas et al.
EUROPEAN RADIOLOGY (2019)
Imaging of Prostate-Specific Membrane Antigen with Small-Molecule PET Radiotracers: From the Bench to Advanced Clinical Applications
Steven P. Rowe et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Renal cell carcinoma: predicting RUNX3 methylation level and its consequences on survival with CT features
Dongzhi Cen et al.
EUROPEAN RADIOLOGY (2019)
A Deep Learning-Based Radiomics Model for Differentiating Benign and Malignant Renal Tumors
Leilei Zhou et al.
TRANSLATIONAL ONCOLOGY (2019)
Deep learning and radiomics: the utility of Google TensorFlow Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT
Heidi Coy et al.
ABDOMINAL RADIOLOGY (2019)
CT-based machine learning model to predict the Fuhrman nuclear grade of clear cell renal cell carcinoma
Fan Lin et al.
ABDOMINAL RADIOLOGY (2019)
Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab
Tadashi Tabei et al.
BMC CANCER (2019)
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update
Giuseppe Lucarelli et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)
Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma
Giuseppe Lucarelli et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)
The Classification of Renal Cancer in 3-Phase CT Images Using a Deep Learning Method
Seokmin Han et al.
JOURNAL OF DIGITAL IMAGING (2019)
Prediction of ISUP grading of clear cell renal cell carcinoma using support vector machine model based on CT images
Xiaoqing Sun et al.
MEDICINE (2019)
A new era: artificial intelligence and machine learning in prostate cancer
S. Larry Goldenberg et al.
NATURE REVIEWS UROLOGY (2019)
Novel imaging techniques of rectal cancer: what do radiomics and radiogenomics have to offer? A literature review
Natally Horvat et al.
ABDOMINAL RADIOLOGY (2019)
Radiogenomics: bridging imaging and genomics
Zuhir Bodalal et al.
ABDOMINAL RADIOLOGY (2019)
Unenhanced CT Texture Analysis of Clear Cell Renal Cell Carcinomas: A Machine Learning-Based Study for Predicting Histopathologic Nuclear Grade
Burak Kocak et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2019)
Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
Sarah R. Verhoeff et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study
Ankur Goyal et al.
ABDOMINAL RADIOLOGY (2019)
Artificial intelligence-based versus manual assessment of prostate cancer in the prostate gland: a method comparison study
Mike A. Mortensen et al.
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING (2019)
Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma
Vidhya Karivedu et al.
CURRENT UROLOGY REPORTS (2019)
TCGA-TCIA Impact on Radiogenomics Cancer Research: A Systematic Review
Mario Zanfardino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Radiogenomics in Clear Cell Renal Cell Carcinoma: Machine Learning-Based High-Dimensional Quantitative CT Texture Analysis in Predicting PBRM1 Mutation Status
Burak Kocak et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2019)
Differentiation of clear cell and non-clear cell renal cell carcinomas by all-relevant radiomics features from multiphase CT: a VHL mutation perspective
Zhi-Cheng Li et al.
EUROPEAN RADIOLOGY (2019)
Juxtatumoral perinephric fat analysis in clear cell renal cell carcinoma
Tania S. Gill et al.
ABDOMINAL RADIOLOGY (2019)
Differentiation of renal angiomyolipoma without visible fat from renal cell carcinoma by machine learning based on whole-tumor computed tomography texture features
En-Ming Cui et al.
ACTA RADIOLOGICA (2019)
The Harms of Overdiagnosis and Overtreatment in Patients with Small Renal Masses: A Mini-review
Ericka M. Sohlberg et al.
EUROPEAN UROLOGY FOCUS (2019)
Radiogenomics in Clear Cell Renal Cell Carcinoma: Correlations Between Advanced CT Imaging (Texture Analysis) and MicroRNAs Expression
Chiara Marigliano et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
Machine learning-based quantitative texture analysis of CT images of small renal masses: Differentiation of angiomyolipoma without visible fat from renal cell carcinoma
Zhichao Feng et al.
EUROPEAN RADIOLOGY (2018)
Background, Current Role, and Potential Applications of Radiogenomics
Katja Pinker et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2018)
Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI
Anqin Li et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients
Jill Rachel Mains et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Differentiating solid, non-macroscopic fat containing, enhancing renal masses using fast Fourier transform analysis of multiphase CT
Bino A. Varghese et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Integrative radiomics expression predicts molecular subtypes of primary clear cell renal cell carcinoma
Q. Yin et al.
CLINICAL RADIOLOGY (2018)
CT-based radiomic model predicts high grade of clear cell renal cell carcinoma
Jiule Ding et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
CT and MR imaging for solid renal mass characterization
Kohei Sasaguri et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
FLCN: The causative gene for Birt-Hogg-Dube syndrome
Laura S. Schmidt et al.
GENE (2018)
Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH
Qiu-Yuan Xia et al.
HISTOPATHOLOGY (2018)
Radiomics of CT Features May Be Nonreproducible and Redundant: Influence of CT Acquisition Parameters
Roberto Berenguer et al.
RADIOLOGY (2018)
Assessment of multiphasic contrast-enhanced MR textures in differentiating small renal mass subtypes
Uyen N. Hoang et al.
ABDOMINAL RADIOLOGY (2018)
Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement
Anna K. Paschall et al.
ABDOMINAL RADIOLOGY (2018)
Differentiation of Predominantly Solid Enhancing Lipid-Poor Renal Cell Masses by Use of Contrast-Enhanced CT: Evaluating the Role of Texture in Tumor Subtyping
Bino A. Varghese et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
Textural differences between renal cell carcinoma subtypes: Machine learning-based quantitative computed tomography texture analysis with independent external validation
Burak Kocak et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
Role of contrast-enhanced F-18-FDG PET/CT imaging in the diagnosis and staging of renal tumors
Cihan Guendogan et al.
NUCLEAR MEDICINE COMMUNICATIONS (2018)
Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer
Ahmad Chaddad et al.
CANCERS (2018)
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
Giuseppe Lucarelli et al.
AGING-US (2018)
Clear cell renal cell carcinoma: CT-based radiomics features for the prediction of Fuhrman grade
Jun Shu et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
Predicting Gleason Score of Prostate Cancer Patients Using Radiomic Analysis
Ahmad Chaddad et al.
FRONTIERS IN ONCOLOGY (2018)
Diagnostic value of F-18 FDG PET/CT for local and distant disease relapse surveillance in surgically treated RCC patients: Can it aid in establishing consensus follow up strategy?
Mai Amr Elahmadawy et al.
NUCLEAR MEDICINE REVIEW (2018)
Reliable gene mutation prediction in clear cell renal cell carcinoma through multi-classifier multi-objective radiogenomics model
Xi Chen et al.
PHYSICS IN MEDICINE AND BIOLOGY (2018)
Subjective and objective heterogeneity scores for differentiating small renal masses using contrast-enhanced CT
Shuai Leng et al.
ABDOMINAL RADIOLOGY (2017)
Voxel-based whole-lesion enhancement parameters: a study of its clinical value in differentiating clear cell renal cell carcinoma from renal oncocytoma
Frank Chen et al.
ABDOMINAL RADIOLOGY (2017)
The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC)
Chiara Nicolazzo et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Adoption of Robot-Assisted Partial Nephrectomies: A Population-Based Analysis of US Surgeons from 2004 to 2013
Hoiwan Cheung et al.
JOURNAL OF ENDOUROLOGY (2017)
Radiomics: the bridge between medical imaging and personalized medicine
Philippe Lambin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T1-2 N0 M0 renal cell carcinoma
Michele Marchioni et al.
WORLD JOURNAL OF UROLOGY (2017)
CT texture analysis: a potential tool for prediction of survival in patients with metastatic clear cell carcinoma treated with sunitinib
Masoom A. Haider et al.
CANCER IMAGING (2017)
Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of 99mTc-sestamibi SPECT/CT
Antonios Tzortzakakis et al.
EJNMMI RESEARCH (2017)
Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression
Steven P. Rowe et al.
EJNMMI RESEARCH (2017)
Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography
Heidi Coy et al.
ABDOMINAL RADIOLOGY (2017)
Texture analysis as a radiomic marker for differentiating renal tumors
HeiShun Yu et al.
ABDOMINAL RADIOLOGY (2017)
The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas
Mark W. Ball et al.
EUROPEAN UROLOGY FOCUS (2017)
CT Intensity Distribution Curve (Histogram) Analysis of Patients Undergoing Antiangiogenic Therapy for Metastatic Renal Cell Carcinoma
Johannes Boos et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2017)
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
Jozefina Casuscelli et al.
JCI INSIGHT (2017)
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT
Pierpaolo Alongi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial
Neema Jamshidi et al.
EUROPEAN RADIOLOGY (2016)
SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery
Neetu Saxena et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery
Neetu Saxena et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
TFEB-amplified Renal Cell Carcinomas An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity
Pedram Argani et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Imaging genomics in cancer research: limitations and promises
Harrison X. Bai et al.
BRITISH JOURNAL OF RADIOLOGY (2016)
SnapShot: Renal Cell Carcinoma
Christopher J. Ricketts et al.
CANCER CELL (2016)
Prospective Evaluation of 99mTc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors
Michael A. Gorin et al.
EUROPEAN UROLOGY (2016)
Radiomics: Images Are More than Pictures, They Are Data
Robert J. Gillies et al.
RADIOLOGY (2016)
Genetic predisposition to kidney cancer
Laura S. Schmidt et al.
SEMINARS IN ONCOLOGY (2016)
Radiomics Analysis on FLT-PET/MRI for Characterization of Early Treatment Response in Renal Cell Carcinoma: A Proof-of-Concept Study
Jacob Antunes et al.
TRANSLATIONAL ONCOLOGY (2016)
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets
Ying-Bei Chen et al.
NATURE COMMUNICATIONS (2016)
Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour
Handoo Rhee et al.
EJNMMI RESEARCH (2016)
Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group
Atul B. Shinagare et al.
ABDOMINAL IMAGING (2015)
Angiomyolipoma with Minimal Fat: Differentiation From Clear Cell Renal Cell Carcinoma and Papillary Renal Cell Carcinoma by Texture Analysis on CT Images
Lifen Yan et al.
ACADEMIC RADIOLOGY (2015)
Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT
Kohei Sasaguri et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2015)
Short-term pretreatment with a dual 5α-reductase inhibitor before bipolar transurethral resection of the prostate (B-TURP): evaluation of prostate vascularity and decreased surgical blood loss in large prostates
Gian Maria Busetto et al.
BJU INTERNATIONAL (2015)
Initial Experience Using 99mTc-MIBI SPECT/CT for the Differentiation of Oncocytoma From Renal Cell Carcinoma
Steven P. Rowe et al.
CLINICAL NUCLEAR MEDICINE (2015)
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer
Giuseppe Lucarelli et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Imaging Findings of Common Benign Renal Tumors in the Era of Small Renal Masses: Differential Diagnosis from Small Renal Cell Carcinoma - Current Status and Future Perspectives
Sungmin Woo et al.
KOREAN JOURNAL OF RADIOLOGY (2015)
Hyperhomocysteinemia as an Early Predictor of Erectile Dysfunction International Index of Erectile Function (IIEF) and Penile Doppler Ultrasound Correlation With Plasma Levels of Homocysteine
Riccardo Giovannone et al.
MEDICINE (2015)
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma
Giuseppe Lucarelli et al.
MEDICINE (2015)
Molecular genetics and clinical features of Birt-Hogg-Dube syndrome
Laura S. Schmidt et al.
NATURE REVIEWS UROLOGY (2015)
The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma
Neema Jamshidi et al.
RADIOLOGY (2015)
MiT family translocation renal cell carcinoma
Pedram Argani
SEMINARS IN DIAGNOSTIC PATHOLOGY (2015)
Racial Disparities in Postoperative Complications After Radical Nephrectomy: A Population-based Analysis
Benjamin I. Chung et al.
UROLOGY (2015)
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma
Giuseppe Lucarelli et al.
ONCOTARGET (2015)
Radiogenomics: What It Is and Why It Is Important
Maciej A. Mazurowski
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY (2015)
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma
Steffen Durinck et al.
NATURE GENETICS (2015)
Imaging-genomic pipeline for identifying gene mutations using three-dimensional intra-tumor heterogeneity features
Payel Ghosh et al.
JOURNAL OF MEDICAL IMAGING (2015)
CT Texture Analysis of Renal Masses: Pilot Study Using Random Forest Classification for Prediction of Pathology
Siva P. Raman et al.
ACADEMIC RADIOLOGY (2014)
Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma
N. Bharwani et al.
BRITISH JOURNAL OF CANCER (2014)
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Caleb F. Davis et al.
CANCER CELL (2014)
Defining Early-Onset Kidney Cancer: Implications for Germline and Somatic Mutation Testing and Clinical Management
Brian Shuch et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Molecular Genetics of Clear-Cell Renal Cell Carcinoma
James Brugarolas
JOURNAL OF CLINICAL ONCOLOGY (2014)
Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers
Eric C. Kauffman et al.
NATURE REVIEWS UROLOGY (2014)
Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations between CT Imaging Features and Mutations
Christoph A. Karlo et al.
RADIOLOGY (2014)
Indium-111-labeled Girentuximab ImmunoSPECT as a Diagnostic Tool in Clear Cell Renal Cell Carcinoma
Constantijn H. J. Muselaers et al.
EUROPEAN UROLOGY (2013)
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer
Giuseppe Lucarelli et al.
FUTURE ONCOLOGY (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Integrated molecular analysis of clear-cell renal cell carcinoma
Yusuke Sato et al.
NATURE GENETICS (2013)
Indications for renal fine needle aspiration biopsy in the era of modern imaging modalities
Ema A. Dragoescu et al.
CYTOJOURNAL (2013)
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course
Daiki Ueno et al.
BMC CANCER (2012)
Dual-Tracer PET/CT in Renal Angiomyolipoma and Subtypes of Renal Cell Carcinoma
Chi-lai Ho et al.
CLINICAL NUCLEAR MEDICINE (2012)
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors
Mengtao Xiao et al.
GENES & DEVELOPMENT (2012)
Succinate Dehydrogenase Kidney Cancer: An Aggressive Example of the Warburg Effect in Cancer
Christopher J. Ricketts et al.
JOURNAL OF UROLOGY (2012)
Radiomics: the process and the challenges
Virendra Kumar et al.
MAGNETIC RESONANCE IMAGING (2012)
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma
Guangwu Guo et al.
NATURE GENETICS (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0?ng/ml
Giuseppe Lucarelli et al.
PROSTATE (2012)
NRF2 and cancer: the good, the bad and the importance of context
Michael B. Sporn et al.
NATURE REVIEWS CANCER (2012)
Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling
Julie Adam et al.
CANCER CELL (2011)
Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
Philip J. Stephens et al.
CELL (2011)
Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer
Irfan Kayani et al.
CLINICAL CANCER RESEARCH (2011)
Outcomes of Small Renal Mass Needle Core Biopsy, Nondiagnostic Percutaneous Biopsy, and the Role of Repeat Biopsy
Michael J. Leveridge et al.
EUROPEAN UROLOGY (2011)
Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status
Chiara Bardella et al.
JOURNAL OF PATHOLOGY (2011)
A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses
Tamer Ozulker et al.
NUCLEAR MEDICINE COMMUNICATIONS (2011)
Assessment of Response to Tyrosine Kinase Inhibitors in Metastatic Renal Cell Cancer: CT Texture as a Predictive Biomarker
Vicky Goh et al.
RADIOLOGY (2011)
An overview of the c-MET signaling pathway
Shawna Leslie Organ et al.
Therapeutic Advances in Medical Oncology (2011)
C-11-Acetate PET imaging for renal cell carcinoma
Nobuyuki Oyama et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Radiogenomics: Creating a link between molecular diagnostics and diagnostic imaging
Aaron M. Rutman et al.
EUROPEAN JOURNAL OF RADIOLOGY (2009)
The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency
Jean-Pierre Bayley et al.
BMC MEDICAL GENETICS (2008)
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
Michael L. Nickerson et al.
CLINICAL CANCER RESEARCH (2008)
Identification and characterization of a novel folliculin-interacting protein FNIP2
Hisashi Hasumi et al.
GENE (2008)
Texture analysis of aggressive and nonaggressive lung tumor CE CT images
Omar S. Al-Kadi et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2008)
PET versus SPECT: strengths, limitations and challenges
Arman Rahmim et al.
NUCLEAR MEDICINE COMMUNICATIONS (2008)
BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports
J. R. Toro et al.
JOURNAL OF MEDICAL GENETICS (2008)
[1-11C]acetate uptake is not increased in renal cell carcinoma
J. Kotzerke et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (I-124-cG250) and PET in patients with renal masses: a phase I trial
Chaitanya R. Divgi et al.
LANCET ONCOLOGY (2007)
Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling
Masaya Baba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer
MH Wei et al.
JOURNAL OF MEDICAL GENETICS (2006)
Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations
PJ Pollard et al.
HUMAN MOLECULAR GENETICS (2005)
Hereditary papillary renal carcinoma type I
PG Dharmawardana et al.
CURRENT MOLECULAR MEDICINE (2004)
Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma
S Vanharanta et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Inhibition of HIF2 alpha is sufficient to suppress pVHL-defective tumor growth
K Kondo et al.
PLOS BIOLOGY (2003)
Renal tumors in the Birt-Hogg-Dube syndrome
CP Pavlovich et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
M Ivan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Molecular basis of the VHL hereditary cancer syndrome
WG Kaelin
NATURE REVIEWS CANCER (2002)
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
IPM Tomlinson et al.
NATURE GENETICS (2002)
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
K Kondo et al.
CANCER CELL (2002)
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF
MA Hoffman et al.
HUMAN MOLECULAR GENETICS (2001)
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
M Ohh et al.
NATURE CELL BIOLOGY (2000)
Share Paper
